FJ4-27008-19090
2 vaccinations
10 coded responses
26 check-ins
10 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 945 / CA
- Registered
- 2021-01-04
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-04
Registered in v-safe
-
2021-01-04
Dose 1 — Moderna
- 2021-01-04
- 2021-01-05
- 2021-01-06
- 2021-01-07
- 2021-01-08
- 2021-01-09
- 2021-01-10
- 2021-01-11
-
2021-01-18
Survey response — day 14, dose 1MedDRA: Cough, Dyspnoea, Fatigue, Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Rhinorrhoea, SARS-CoV-2 test negative — Feeling: Good · Be unable to workFree text: 1. Itching, redness, hard swelling at injection site-resolved2. Cough, runny nose, fatigue, shortness of breath - improving now. Negative COVID resultMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-18
- 2021-01-25
-
2021-02-01
Dose 2 — Moderna
-
2021-02-01
Survey response — day 0, dose 2MedDRA: Head discomfort — Feeling: Good · Site: Pain, Itching · Fatigue or tirednessFree text: Mild head rushMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-02
Survey response — days 1–6 daily, dose 2MedDRA: Paranasal sinus discomfort — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesFree text: Sinus discomfortMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-03
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-04
Survey response — days 1–6 daily, dose 2MedDRA: Cough, Rhinorrhoea, Sneezing — Feeling: Fair · Site: Itching · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Runny nose, sneezing, coughMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-05
Survey response — days 1–6 daily, dose 2MedDRA: Feeling abnormal — Feeling: Fair · Site: Itching · Headache, Fatigue or tiredness, Nausea · Be unable to workFree text: In retrospect I have felt mentally cloudy ever since vaccine dose #2MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-06
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Itching · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-08
- 2021-02-15
-
2021-02-22
Survey response — day 21, dose 2MedDRA: Fatigue, Malaise — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Abrupt onset fatigue>malaise on Thursday evening, continuing through Friday, improving since then. No other clear symptoms, no one around with similar symptomsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-22
Report sent to call center — day 21, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-03-01
Survey response — day 28, dose 2MedDRA: Fatigue, Headache, Malaise, Nausea — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Recurrent bouts of malaise/fatigue/nausea /headache. The symptoms are intense for several hours to a day then gradually improve, but I havent been back at baseline for 2 weeksMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-08
Survey response — day 35, dose 2MedDRA: Anxiety, Fatigue, Insomnia, Mood altered — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Persistent fatigue though better than last week. Insomnia and anxiety, some mood changes. Not sure if that is just because of not knowing when these symptoms will resolveMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-15
Survey response — day 42, dose 2MedDRA: Fatigue, Headache, Insomnia, Malaise — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Ongoing waxing/waning fatigue/malaise /headache. InsomniaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-03
Survey response — 3 months, dose 2MedDRA: Fatigue, Office visit — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Ongoing fatigue esp with exertion, still not back to baseline · Healthcare visit (other): MRI, treadmill, labsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-03
Report sent to call center — 3 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-14
- 2021-07-01
- 2021-08-02
- 2022-02-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-04 | Moderna | |
| 2 | 2021-02-01 | Moderna |
Call center
3 call center cases
2 unsuccessful · 1 priority 2/3 (triaged and no follow up)
Free text
Release 2 — day 14, dose 1
Symptoms: 1. Itching, redness, hard swelling at injection site-resolved2. Cough, runny nose, fatigue, shortness of breath - improving now. Negative COVID result
Release 3 — day 0, dose 2
Systemic reaction (other): Mild head rush
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Sinus discomfort
Systemic reaction (other): Runny nose, sneezing, cough
Systemic reaction (other): In retrospect I have felt mentally cloudy ever since vaccine dose #2
Release 4 — day 21, dose 2
Symptoms: Abrupt onset fatigue>malaise on Thursday evening, continuing through Friday, improving since then. No other clear symptoms, no one around with similar symptoms
Release 4 — day 28, dose 2
Symptoms: Recurrent bouts of malaise/fatigue/nausea /headache. The symptoms are intense for several hours to a day then gradually improve, but I havent been back at baseline for 2 weeks
Release 5 — day 35, dose 2
Symptoms: Persistent fatigue though better than last week. Insomnia and anxiety, some mood changes. Not sure if that is just because of not knowing when these symptoms will resolve
Release 5 — day 42, dose 2
Symptoms: Ongoing waxing/waning fatigue/malaise /headache. Insomnia
Release 8 — 3 months, dose 2
Symptoms: Ongoing fatigue esp with exertion, still not back to baseline
Healthcare visit (other): MRI, treadmill, labs
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Anxiety | ✓ | ✓ | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Injection site induration | ✓ | ✓ | ✓ |
| SD | Injection site pruritus | ✓ | ✓ | ✓ |
| SD | Injection site swelling | ✓ | ✓ | ✓ |
| SD | Insomnia | ✓ | ✓ | ✓ |
| SD | Malaise | ✓ | ✓ | ✓ |
| SD | Mood altered | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | ✓ | ✓ |
| SRO | Cough | ✓ | ✓ | ✓ |
| SRO | Feeling abnormal | ✓ | ✓ | ✓ |
| SRO | Head discomfort | ✓ | ✓ | ✓ |
| SRO | Paranasal sinus discomfort | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
| SRO | Sneezing | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release